An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Brain
Interventions: OTHER: Copper Cu 64-DOTA-Trastuzumab|PROCEDURE: Magnetic Resonance Imaging|DEVICE: Positron Emission Tomography|BIOLOGICAL: Trastuzumab|BIOLOGICAL: Trastuzumab Deruxtecan
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)